Related Experiment Video
Updated: May 17, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Emergence of Sprouty role from the signaling interplay of DUSP1 and DUSP4 interactions in NSCLC pathogenesis
Manasi Tukrul1,2, Pooja Gulhane1, Shailza Singh3,4
1Biotechnology Research and Innovation Council, National Centre for Cell Science, Pune, India.
Abstract:
Non-small cell lung cancer (NSCLC), the predominant subtype of lung cancer, remains a major global health challenge due to its complex etiology and resistance to therapy. Aberrant signaling through receptor tyrosine kinases (RTKs) and mitogen-activated protein kinases (MAPKs) drives tumor progression and immune modulation, underscoring the need for systems-level investigation. In this study, we employed mathematical modeling and experimental validation to dissect the dynamic interplay of EGFR, FGFR, and TNFR signaling in NSCLC cells and macrophages. Our flux-based sensitivity analysis revealed persistent pathway biases, highlighting DUSP1, DUSP4, and SPRY2 as critical high-flux regulators within the MAPK and PI3K/AKT cascades. Crosstalk analysis demonstrated that these proteins form an interconnected signaling axis influencing cytokine production (IL6, IL10, IL12, and TNF-α) and macrophage-mediated responses in the tumor microenvironment. Functional assays confirmed that silencing SPRY2 suppressed DUSP1 and DUSP4 expression, impaired cell migration, and induced G2/M arrest, establishing a coordinated regulatory network essential for NSCLC progression. Together, our findings integrate computational modeling with molecular validation to identify DUSP1, DUSP4, and SPRY2 as pivotal drivers of oncogenic signaling and immune regulation. These proteins represent promising therapeutic targets whose inhibition may disrupt tumor-promoting feedback loops and attenuate NSCLC growth and survival.
Insights
Mathematical modeling reveals DUSP1, DUSP4, and SPRY2 are key regulators in non-small cell lung cancer (NSCLC) signaling. Inhibiting these proteins may offer new therapeutic strategies for NSCLC by disrupting tumor growth and immune evasion.
Area of Science:
- Oncology
- Systems Biology
- Immunology
Background:
- Non-small cell lung cancer (NSCLC) presents significant therapeutic challenges due to complex signaling pathways and treatment resistance.
- Aberrant receptor tyrosine kinase (RTK) and mitogen-activated protein kinase (MAPK) signaling drive tumor progression and immune modulation in NSCLC.
Purpose of the Study:
- To investigate the dynamic interplay of EGFR, FGFR, and TNFR signaling in NSCLC using mathematical modeling and experimental validation.
- To identify critical regulators within MAPK and PI3K/AKT cascades influencing the tumor microenvironment and immune responses.
Main Methods:
- Employed mathematical modeling with flux-based sensitivity analysis to dissect signaling networks.
- Conducted crosstalk analysis to understand protein interactions and their impact on cytokine production.
- Utilized functional assays, including gene silencing, to validate regulatory roles.
Main Results:
- Identified DUSP1, DUSP4, and SPRY2 as high-flux regulators in MAPK and PI3K/AKT pathways.
- Demonstrated that these proteins form an axis influencing cytokine production (IL6, IL10, IL12, TNF-α) and macrophage responses.
- Silencing SPRY2 impaired NSCLC cell migration and induced cell cycle arrest, confirming a coordinated regulatory network.
Conclusions:
- DUSP1, DUSP4, and SPRY2 are pivotal drivers of oncogenic signaling and immune regulation in NSCLC.
- These proteins represent potential therapeutic targets for disrupting feedback loops that promote NSCLC growth and survival.
- Integration of computational modeling and experimental validation provides a systems-level understanding of NSCLC pathogenesis.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hedgehog Signaling Pathway

